Therefore, the expression of MAP17 triggers chronic inflammation not only in cancer but in various inflammatory diseases such as Barret’s esophagus, lupus, Crohn’s, psoriasis and COPD. This evidence concerns the gene PDZK1IP1 and systemic lupus erythematosus.